Toward a genetics of cancer resistance

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 3, 2009, Pages 859-863

  Klein, George ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER RESISTANCE; CANCER TISSUE; CARCINOGENICITY; CELL HYBRIDIZATION; DNA REPAIR; EPIGENETICS; GENE; GENE ACTIVATION; GENE NUMBER; GENETIC VARIABILITY; GENOME IMPRINTING; GENOTYPE; HUMAN; MICROENVIRONMENT; MOLECULAR EVOLUTION; NEOPLASM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SMOKING;

ANIMALS; APOPTOSIS; DNA REPAIR; EPIGENESIS, GENETIC; EVOLUTION; GENETIC VARIATION; GENOMIC IMPRINTING; HUMANS; HYBRIDIZATION, GENETIC; MICE; NEOPLASMS; ONCOGENES;

EID: 58849118590     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0811616106     Document Type: Article

References (54)

1. Weinberg RA (2007) The Biology of Cancer (Garland Science Publishers, New York).
2. Bremner R, Balmain A (1990) Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61:407-420.
3. Balmain A, Nagase H (1998) Cancer resistance genes in mice: Models for the study of tumor modifiers. Trends Genet 14:139-144.
4. Nagase H, et al. (1995) Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat Genet 10:424-429.
5. Manenti G, et al. (1996) Genetic mapping of a pulmonary adenoma resistance locus (Par1) in mouse. Nat Genet 12:455-457.
6. Pharoah PD, et al. (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36.
7. Klein G, Imreh S, Zabarovsky ER (2007) Why dowe not all die of cancer at an early age? Adv. Cancer Res 98:1-16.
8. Svanborg C, et al. (2003) HAMLET kills tumor cells by an apoptosis-like mechanism-cellular, molecular, and therapeutic aspects. Adv Cancer Res 88:1.
9. Torsteinsdottir S, et al. (1986) Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. PNAS 83:5620-5624.
10. Amyes E, et al. (2003) Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 198:903-911.
11. Halpert R, et al. (1986) Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 68:251-258.
12. Lagos D, Boshoff C (2007) Immunobiology and host response to KSHV infection. In Human Herpesviruses, ed Arvin A (Cambridge University Press, Cambridge, United Kingdom) 52:915-928.
13. Noy A (2007) Update on HIV lymphoma. Curr Oncol Rep 9:384-390.
14. Ma CS, Nichols KM, Tangye SW (2007) Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Ann Rev Immunol 25:337-379.
15. Klein G (1994) Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791-793.
16. Callan MFC (1998) Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187:1395-1402.
17. Fleckenstein B, Ensser A (2007) Gammaherpesviruses of New World primates. Arvin A, ed. Human Herpesviruses (Cambridge University Press, Cambridge, United Kingdom), pp. 1076-1092.
18. Klein G, et al. (1973) Antibody reactions to Herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys. Int J Cancer 12:270-289.
19. Shiina T, et al. (2007) Extended gene map reveals tripartite motif, C-type lectin, and Ig superfamily type genes within a subregion of the chicken MHC-B affecting infectious disease. J Immunol 178:7162-7172.
20. Old LJ (2007) Cancer is somatic cell pregnancy. Cancer Immun 6:7-19.
21. Dworaczek H, Xiao W (2007) Xeroderma pigmentosum: A glimpse into nucleotide excision repair, genetic instability, and cancer. Crit Rev Oncog 13:159-177.
22. Li GM (2008) Mechanisms and functions of DNA mismatch repair. Cell Res 18:85-98.
23. Takahashi M, et al. (2007) Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res 67:4595-4604.
24. Gras E, et al. (2001) Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer 92:2829-2836.
25. Xie Y et al. (2004) Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res 64:3096-3102.
26. Hung RJ, Hall J, Brennan P, Bofetta P (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am J Epidemiol 162:925-942.
27. Bond GL, Hu W, Levine A (2005) A single nucleotide polymorphism in the MDM2 gene: From a molecular and cellular explanation to clinical effect. Cancer Res 65:5481-5484.
28. Soussi T, Wiman K (2007) Shaping genetic alterations in human cancer: The p53 Mutation Paradigm. Cancer Cell 12:303-312.
29. Potter M (2007) The early history of plasma cell tumors in mice, 1954-1976. Adv Cancer Res 98:17-51.
30. Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254.
31. Zhang S, et al. (2003) p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene 22:2285-2295.
32. Lindstrom MS, Wiman KG (2002) Role of genetic and epigenetic changes in Burkitt lymphoma. Semin Cancer Biol 12:381-387.
33. Cui H, et al. (2003) Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 299:1753-1755.
34. Sakatani T, et al. (2005) Loss of imprinting of IGF2 alters intestinal maturation and tumorigenesis in mice. Science 307:1976-1978.
35. Holm TM, et al. (2005) Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8:275-285.
36. Stoker MG, Shearer M, O'Neill C (1966) Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1:297-310.
37. Bignami M, Rosa S, La Rocca SA, Falcone G, Tatò F (1988) Differential influence of adjacent normal cells on the proliferation of mammalian cells transformed by the viral oncogenes myc, ras and src. Oncogene 2:509-514.
38. Borek C, Sachs L (1966) The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc Natl Acad Sci USA 56:1705-1711.
39. Glick AB, Yuspa SH (2005) Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers. Semin Cancer Biol 15:75-83.
40. Alt-Holland A, Zhang W, Marguilis A, Garlick JA (2005) Microenvironmental control of premalignant disease: The role of intercellular adhesion in the progression of squamous cell carcinoma. Semin Cancer Biol 15:84-96.
41. Weaver VM, et al. (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231-345.
42. Naumov GN, et al. (2002) Persistence of solitary mammary carcinoma cells in a secondary site: A possible contributor to dormancy. Cancer Res 62:2162-2168.
43. Mintz B, Illmensee K (1975) Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 72:3585-3589.
44. Nelson CM, Bissell MJ (2005) Modeling dynamic reciprocity: Engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 15:342-352.
45. Dolberg DS, Nelson CM, Bissell MJ (1985) Wounding and its role in RSV-mediated tumor formation. Science 230:676-678.
46. Alexander DB, et al. (2004) Normal cells control the growth of neighboring transformed cells independent of gap junctional communication and Src activity. Cancer Res 64:1347-1358.
47. Wang F, et al. (2002) Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 94:1494-1503.
48. Margulis A, et al. (2003) Abrogation of E-cadherin-mediated adhesion induces tumor cell invasion in human skin-like organotypic culture. J Invest Dermatol 121:1182-1190.
49. Zhang W (2001) Escaping the stem cell compartment: Sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc Natl Acad Sci USA 98:13948-13953.
50. Hennings H, et al. (1992) Activity of diverse tumor promoters in a keratinocyte co-culture model of initiated epidermis. Carcinogenesis 13:2145-2151.
51. Heston WE (1959) Genetics and Cancer. (University of Texas Press, Austin, TX), pp 226-240.
52. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C (2004) The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 117:1495-1502.
53. Klein G (1976) Analysis of malignancy and antigen expression by cell fusion. Fed Proc 35:2202-2204.
54. Wang F, et al. (2008) HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro. PLoS ONE 22:3.